HUNTINGTON, W.Va. (WCHS) — Nearly $500,000 in federal funding has been earmarked for a Huntington facility that supports infants suffering from Neonatal Abstinence Syndrome. Lily’s Place is set to ...

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” Phase 1/2 study, according to drugmaker uniQure, marking a major step toward a potential first ...

Huntington’s disease is a rare and incurable hereditary disorder that damages brain cells. Early signs include coordination problems and memory lapses. In the later stages, people may need full-time ...

Many clinical trials for Huntington’s disease care are underway, with the hope of one day finding treatment to slow or stop disease progression. Huntington’s disease is a progressive neurological ...

Researchers at the University of Leeds and Lancaster University in the UK have identified a new potential target for the treatment of Alzheimer's disease—PDE4B. Their work is published in ...

Huntington’s disease is a genetic disorder — or inherited condition — that causes progressive deterioration of the brain cells, or neurons. The condition develops due to mutations, or changes, in the ...